Submit Manuscript    >>    Login | Register


Search Result for Douglas S. Holmes, MD

Title: The Safety of Dabigatran Versus Warfarin in Patients Undergoing Atrial Fibrillation Ablation

Credits: Luis I. Garcia, MD, Kartikya Ahuja, MD, Mark A. Mascarenhas, MD, Anthony Aizer, MD, Neil Bernstein, MD, Scott A. Bernstein, MD, Steve J. Fowler, MD, Douglas S. Holmes, MD, David S. Park, MD, Larry Chinitz, MD

Title: Abnormal Left Ventricular Filling and Postoperative Atrial Fibrillation after Cardiac Surgery

Credits: Florian Rader, MD, MSc, Rama Dilip Gajulapalli, MD, Tilak Pasala, MD, Douglas Einstadter, MD, MPH

Title: Gender and Racial Characteristics of Patients Referred to a Tertiary Atrial Fibrillation Center

Credits: Pamela K. Mason, MD, Liza Moorman, RN, ACNP-BC, Douglas E. Lake, PhD, J. Michael Mangrum, MD, John P. DiMarco, MD, PhD, John D. Ferguson, MBChB, MD, Srijoy Mahapatra, MD, Kenneth C. Bilchick, MD, David Wiggins, BS, RN, J. Paul Mounsey, MD, PhD, J. Randall Moorman, MD

  • Dr. Abhinav Sharma, MD.

    Affiliation: Assistant Professor of Medicine at the University of Missouri School of Medicine and Truman Medical Center in Kansas City, Missouri , United States of America. Main research interests involve cardiovascular imaging, vulnerable atherosclerotic plaque, and cardiovascular quality and outcomes.

  • Dr. David R. Holmes, Jr., MD.

    Affiliation: David R. Holmes, Jr., MD is a Professor of Medicine at Mayo Clinic College of Medicine and Consultant. He is also a Past President of the American College of Cardiology and the Society for Cardiac Angiography and Interventions. He acts as editorial board member and is a reviewer of several professional journals including among others the American Journal of Cardiology, Journal of the American College of Cardiology, International Journal of Cardiology, and Catheterization and Cardiovascular Interventions. In addition, he is involved in the development of new catheter design and new approaches for treatment of a wide variety of patients with coronary artery disease and vein graft disease. Finally, he is involved in the development of continued application of percutaneous coronary intervention technology to noncoronary vascular beds and left atrial appendage occlusion.

  • Biosense Webster
    event date
    Introduction to AFib
    Ablation Specialist

    View Ablation Specialists